Search

everythinglearnresearchcommunity

for

Search:↓

5ARI treatment improves PSA test accuracy for prostate cancer diagnosis.

5α-reductase inhibitors effectively treat enlarged prostate and hair loss but require careful use due to possible side effects.

New nonsteroidal molecules can potentially increase dihydrotestosterone in neurons by blocking certain enzymes, without affecting prostate and seminal vesicle weight.

The compound was successfully made and shows potential for treating prostate cancer.

Some prostate cancers have gene changes that may affect treatment with certain drugs.

5alpha-reductase inhibitors like finasteride and dutasteride effectively treat BPH by reducing DHT, offering symptom relief and potential future uses.

Women with severe acne, hirsutism, and androgenic alopecia often have higher levels of certain androgens, but the specific pattern can't be predicted just by looking at symptoms.

Male yak hair growth is influenced by DHT synthesis, which is promoted by 5α-red1 and AR during growth phases, while E2 may inhibit growth through ERα.

The method accurately measures testosterone metabolites with high sensitivity and low environmental impact.

New genes and pathways are important for testosterone production and male sexual development.

5α-reductase inhibitors like finasteride and dutasteride effectively treat BPH by reducing DHT levels.

Testosterone undecanoate can reduce the negative effects of Finasteride on male reproductive health.

Phytosterols may help manage prostate issues but are less effective than synthetic drugs.

New A-homo-B, 19-dinor steroids showed strong antiandrogenic activity without affecting the enzyme 5α-reductase or androgen receptor binding.

5α-reductase inhibitors help treat prostate enlargement and hair loss but may cause side effects, requiring careful use.

Finasteride effectively reduces DHT and E2 levels, helping with prostate enlargement.

Testosterone and some of its forms can strongly stimulate oil gland growth in skin.

Five-alpha reductase inhibitors, like finasteride and dutasteride, can treat enlarged prostates, improve urination, reduce need for prostate surgery, and lower the risk of prostate cancer, but may increase the risk of higher grade prostate cancer. They can also treat male pattern baldness.

New testosterone analogs show promise for male contraception with better activity and potentially fewer side effects.

Dutasteride more effectively lowers DHT levels in men with enlarged prostates than finasteride.

5α-reductase inhibitors may cause persistent sexual dysfunction and depression, needing more research on long-term effects.

Urtica laetevirens extract significantly reduces 5α-reductase activity.

Neurosteroids help control dopamine responses in the brain.

Finasteride is made through a series of chemical reactions starting from a specific intermediate compound.

DHT is needed for long-term depression, while E2 is needed for full long-term potentiation in male rat brains.

Finasteride reduces prostate size and DHT in male mastomys but not in females.

Estrogen deficiency can reduce the enzyme activity needed to activate vitamin D.

Testosterone works in different ways, including direct interaction with its receptor, conversion to other hormones for specific effects on genitalia, hair, bones, and muscle, and changes in body fat and sexual function when low.

Plant-based compounds might be a promising alternative for prostate cancer treatment with fewer side effects.

DHEA supplementation may improve quality of life, neuropsychological functions, and sexual satisfaction in individuals with adrenal insufficiency, but more research is needed to confirm its safety and effectiveness.